Business

Ansell Capital Corp. Completes Drilling on Pires Project in Brazil

Ansell Capital Corp. Completes Drilling on Pires Project in Brazil

articleBriacell Therapeutics CorpMay 13, 20105/company/briacell-therapeutics-corp/news/ansell-capital-corp-completes-drilling-on-pires-project-in-brazil
Ansell Capital Corp. Completes Drilling on Pires Project in Brazil

About this update from Briacell Therapeutics Corp

[{"type":"text","content":"\nAnsell Capital Corp. Completes Drilling on Pires Project in Brazil\n\n\n May 13, 2010 (TheNewswire.ca) -- Ansell Capital Corp. (ACP-TSX.V) and Entourage Mining Ltd. (OTCBB:ENMGF) are pleased to announce completion of the first preliminary drill program at the Point 1 target on the Pires Property in Goiás State, Brazil. This first drill program totaled four drill holes. Dr. Harrison Cookenboo, P.Eng reports the holes intersected undeformed quartz veins in schist with variable quantities of disseminated sulphides. The quartz veins correlate vertically with surface exposures of the quartz veins which are the source of previously reported high gold values (see News Release dated April 7, 2010).The drill core has been logged in the field, sawn, and sampled, with samples delivered to a Brazilian laboratory. Results are expected soon and will be reported when completed.On February 18, 2010 Ansell announced that it had signed a Letter of Intent (\"LOI\") with Entourage Mining Ltd., wherein Ansell has agreed to complete due diligence on 6 mineral claims covering 8,798 hectares of mineral explorations lands and incur expenditure on the claims of no less than US$200,000. (see News Release Dated February 18th, 2010)Dr. Cookenboo is the qualified person for the company as defined by National Instrument 43-101 who has reviewed the contents of this release.ON BEHALF OF THE BOARD OF DIRECTORSANSELL CAPITAL CORP\"Jevin Werbes\"Jevin WerbesPresident & CEOFor further information, please visit our website at www.ansellcapital.com or www.sedar.com to view the Company's profile or contact Ansell at 604-921-1810.The TSX Venture Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of the content of this News Release. WARNING: The Company relies on litigation protection for \"forward looking\" statements. Actual results could differ materially from those described in the news release as a result of numerous factors, some of which are outside the control of the Company.Copyright (c) 2010 Thenewswire.ca - All rights reserved.\n\n\n\n","length":2341,"tagName":"div"}]

More updates from Briacell Therapeutics Corp